Neuronostics forms strategic partnership to deliver integrated EEG solutions for clinical trials 

Posted by 

SETsquared Bristol

Neuroelectrics, a pioneer in high-definition brain stimulation and EEG technology, has partnered with Neuronostics, an innovator in advanced digital biomarkers and EEG analysis, to deliver an integrated EEG solution tailored for the pharmaceutical, contract research organizations (CROs) and academic partners. This collaboration combines Neuroelectrics’ cutting-edge EEG hardware with Neuronostics’ proprietary analytics to streamline clinical trials and unlock new possibilities in neurological research.

A Game-Changing Collaboration
The partnership addresses a critical need in clinical trials for high-quality, actionable data by providing an integrated platform that accelerates research and improves outcomes. Leveraging Neuronostics’ proprietary BioEP tool and Neuroelectrics’ premium EEG technology, the platform enhances cohort identification, streamlines protocol design, and delivers precise EEG analysis, ensuring trials are both efficient and impactful.

John Terry, Managing Director at Neuronostics, stated:
“This collaboration with Neuroelectrics creates a powerful offering that will enable EEG and digital biomarkers to make clinical trials more efficient and effective, leading to significant benefits for people with neurological conditions.”

Ana Maiques, CEO of Neuroelectrics, commented:
“At Neuroelectrics, we believe in advancing brain health through innovation. Our partnership with Neuronostics elevates clinical trials by integrating the best in EEG technology and analytics, enabling breakthroughs in neurology and psychiatry.

The Power of Integrated EEG Solutions

Targeted Cohort Identification: The integrated EEG tool assists in identifying participants with the highest seizure burden through a brief 20-minute EEG. This targeted approach saves time and enhances statistical significance in trials.

Comprehensive Data Analysis: Certified neurophysiologists combine clinical expertise with Neuronostics’ cloud-based digital tools to deliver robust, actionable EEG insights tailored to trial objectives.

Optimized Protocol Design: Experts collaborate with sponsors to create trial protocols aligned with study goals, ensuring streamlined processes and reliable results.

Learn more about Wilder Sensing: neuronostics.com. 

Find out more about SETsquared Bristol’s incubation programme.  

Recent News, Blogs and Stories

Wilder Sensing team of five people in a field with trees

Wilder Sensing secures investment to propel growth and innovation for biodiversity monitoring 

Wilder Sensing, a developer of software for biodiversity monitoring using audio and Artificial Intelligence (AI), has secured £700,000 in equity investment.   The South West Investment Fund awarded £300,000 via...
Ferryx exhibiting at SETsquared Investment Futures event

SETsquared event ignites opportunities for startup and spinout investment 

In a vibrant display of entrepreneurial spirit, the SETsquared Partnership highlighted the investment potential of university startups and spinouts at a high-profile event in London last month.  Investment Futures attracted...
Anna-Lisa Wesley wearing blue top in front of grey background

Anna-Lisa Wesley: Founder folklore and fairytales – tech desperately needs new material

Anna-Lisa Wesley, Entrepreneur in Residence at SETsquared Bristol, reflects on the power of storytelling and needing new founder stories for our time. "Working in tech right now, we need some new...

SUCCESS IS THE GOAL

Fast track your technology business